Varizig Injection, Solution
Product Images NDC 49591-126

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Varizig (NDC 49591-126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kamada Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel – 1.2 mL Carton Label (Var00 0005 01)

Packaging label for VARIZIG Liquid (Human Varicella-Zoster Immune Globulin) Injection, solution for intramuscular administration, strength ≥125 IU per 1.2 mL vial. Label shows distribution by Kamada Inc. and manufacturing by Emergent BioSolutions Canada Inc. Contains storage instructions and declaration of non-medicinal ingredients. Includes barcode and U.S. License No. 1826.*

FDA Label Image

Principal Display Panel – 1.2 mL Vial Label (Var00 0005 02)

VARIZIG Liquid Sterile Solution for Injection, Human Varicella Zoster Immune Globulin, with a strength of 125 IU per 1.2 mL. The label indicates intramuscular administration, prescription use only, storage instructions at 2-8°C, and distribution by Kamada Inc., Hoboken NJ. Includes barcodes and placeholder fields for Lot and Expiration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.